“Yiqi Huayu, Wenyang Lishui” Prescription (YHWLP) Improves the Symptoms of Chronic Obstructive Pulmonary Disease-Induced Chronic Pulmonary Heart Disease by Inhibiting the RhoA/ROCK Signaling Pathway
Background. Chronic pulmonary heart disease (CPHD) is a common type of heart disease. In China, chronic obstructive pulmonary disease (COPD) is one of the main causes of CPHD. At present, there is no specific therapy for COPD-induced CPHD, so it is of great importance to identify a new therapy for C...
Guardado en:
Autores principales: | Hui Huang, Kuizhong Shan, Min Cai, Hong Chen, Fengmei Wu, Xiaoyan Zhao, Huawei Zhuang, Hong Li, Suofang Shi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4b8927a38e144f5887b573a03e8a6477 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Activation of Rac-1 and RhoA contributes to podocyte injury in chronic kidney disease.
por: Andrea Babelova, et al.
Publicado: (2013) -
Effect of Huoxue Huayu Lishui Decoction on P65 and TAK1 of acute soft tissue injury in rats
por: Kang Wang, et al.
Publicado: (2021) -
Pulmonary embolism with chronic obstructive pulmonary disease
por: Ruohan Yang, et al.
Publicado: (2021) -
Handbook of Chronic Obstructive Pulmonary Disease
por: Rees, P John -
CHRONIC SUPPURANT PULMONARY DISEASES (LECTURE)
por: E. G. Grigoryev
Publicado: (2014)